Ono Pharmaceutical (OTCMKTS:OPHLF) Posts Earnings Results

Ono Pharmaceutical (OTCMKTS:OPHLF) posted its earnings results on Monday. The company reported $0.21 earnings per share for the quarter, Zacks reports. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.85%.

Ono Pharmaceutical Stock Performance

Shares of OTCMKTS OPHLF remained flat at $9.22 on Monday. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.22 and a quick ratio of 2.80. Ono Pharmaceutical has a 1 year low of $9.22 and a 1 year high of $16.82. The firm has a market capitalization of $4.33 billion, a PE ratio of 6.88 and a beta of 0.59. The stock has a 50-day moving average price of $10.38 and a 200 day moving average price of $12.49.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.